MAYO CLINIC
Q1 2023 Form 13-F
ROCHESTER, MINNESOTA
CIK 0001318153
· Institutional investment manager
$121.8M Reported Value Total
Reported value
$121.8M
Quarter over quarter
+5.4%
Holdings
13
Top-10 concentration
99.9%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Paul A Gorman
Chief Investment Officer
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2023 13F record
Q1 2023 13F filing summary
| Period of report | March 31, 2023 |
|---|---|
| Filed | May 05, 2023 |
| Form | 13F-HR |
| Reported value | $121.8M |
| Positions | 13 |
| Change in reported value | -35.5% |
| New positions | 2 |
| Exited positions | 2 |
| Position turnover | 26.7% |
| Top-10 concentration | 99.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 12, 2024
|
3 | $2.9M |
|
Q2 2024 13F
Filed Aug 12, 2024
|
4 | $3.0M |
|
Q1 2024 13F
Filed May 13, 2024
|
5 | $6.1M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
7 | $16.2M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
9 | $51.9M |
|
Q2 2023 13F
Filed Aug 9, 2023
|
11 | $97.4M |
|
Q1 2023 13F
Filed May 5, 2023
|
13 | $121.8M |
|
Q4 2022 13F
Filed Jan 26, 2023
|
13 | $188.8M |
|
Q2 2021 13F
Filed Aug 12, 2021
|
9 | $90.4M |
|
Q1 2021 13F
Filed May 13, 2021
|
8 | $86.9M |
|
Q4 2020 13F
Filed Feb 11, 2021
|
9 | $83.1M |
|
Q3 2020 13F
Filed Nov 12, 2020
|
9 | $74.2M |
|
Q2 2020 13F
Filed Aug 13, 2020
|
8 | $104.5M |
|
Q1 2020 13F
Filed Apr 24, 2020
|
7 | $39.5M |
|
Q4 2019 13F
Filed Feb 12, 2020
|
8 | $88.2M |
Top 13 holdings · Q1 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ACWI MSCI ACWI ETF | $104.5M | 85.77% |
| 2 | BSM BLACK STONE MINERALS | $10.1M | 8.29% |
| 3 | ZNTL Zentalis Pharmaceuticals Inc | $5.1M | 4.19% |
| 4 | EXAS Exact Sciences | $349.3K | 0.29% |
| 5 | SCLX Scilex Holding Co | $346.9K | 0.28% |
| 6 | MIRO Miromatrix Med Inc | $321.9K | 0.26% |
| 7 | CLPT Clearpoint Neuro Inc | $321.7K | 0.26% |
| 8 | NMTC Neuroone Medical Technologies | $292.6K | 0.24% |
| 9 | UNBX UNITY BIOTECHNOLOGY INC | $256.2K | 0.21% |
| 10 | BSGM BIOSIG TECH INC | $115.0K | 0.09% |
| 11 | EVLO EVELO BIOSCIENCES INC | $86.6K | 0.07% |
| 12 | TDOC Teladoc Health Inc Com | $17.1K | 0.01% |
| 13 | VYNT Vyant Bio Inc | $16.1K | 0.01% |
Values as reported on the Q1 2023 Form 13F. Every position is in the holdings table below.